|
EP1575916B1
(en)
|
2001-08-31 |
2013-05-22 |
The Rockefeller University |
Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
|
|
US20030195205A1
(en)
*
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
KR20040053210A
(ko)
*
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
|
JP4467979B2
(ja)
|
2001-12-06 |
2010-05-26 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有糸分裂キネシン阻害剤
|
|
ES2280596T3
(es)
*
|
2001-12-29 |
2007-09-16 |
Novo Nordisk A/S |
Uso combinado de un compuesto de glp-1 y un inhibidor de una aldosa reductasa.
|
|
IS1935B
(is)
*
|
2002-03-19 |
2004-06-16 |
Actavis Group Hf. |
Fósínópríl lyfjasamsetning
|
|
ATE478872T1
(de)
*
|
2002-03-28 |
2010-09-15 |
Ustav Ex Botan Av Cr V V I I O |
Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
|
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
|
DE10238723A1
(de)
*
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
*
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
US20040220186A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
WO2004099211A1
(de)
*
|
2003-05-09 |
2004-11-18 |
Bayer Healthcare Ag |
6-cyclylmethyl- und 6-alkylmethyl-substituierte pyrazolopyrimidine
|
|
DE10320785A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
|
US8044060B2
(en)
|
2003-05-09 |
2011-10-25 |
Boehringer Ingelheim International Gmbh |
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
|
|
DE102004004142A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
|
|
BRPI0416118A
(pt)
*
|
2003-10-31 |
2007-01-02 |
Pfizer Prod Inc |
inibição da fosfodiesterase 9 como tratamento para estados relacionados com a obesidade
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
EP1751133B1
(en)
*
|
2004-04-28 |
2010-04-14 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
US8673964B2
(en)
|
2004-05-20 |
2014-03-18 |
Diamedica Inc. |
Use of drug combinations for treating insulin resistance
|
|
CN101198614B
(zh)
|
2005-06-14 |
2011-07-06 |
Aska制药株式会社 |
噻吩并嘧啶衍生物
|
|
EP1919287A4
(en)
*
|
2005-08-23 |
2010-04-28 |
Intra Cellular Therapies Inc |
ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR SIGNALING ACTIVITY
|
|
KR101419075B1
(ko)
*
|
2006-08-08 |
2014-07-11 |
아스카 세이야쿠 가부시키가이샤 |
퀴나졸린 유도체
|
|
MEP8509A
(en)
|
2006-09-07 |
2011-12-20 |
|
Combination treatment for diabetes mellitus
|
|
EP2066355A2
(en)
*
|
2006-09-19 |
2009-06-10 |
Braincells, Inc. |
Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
|
|
WO2008072779A1
(ja)
|
2006-12-13 |
2008-06-19 |
Aska Pharmaceutical Co., Ltd. |
キノキサリン誘導体
|
|
AU2007332439A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Aska Pharmaceutical Co., Ltd. |
Therapeutic agent for urinary tract disease
|
|
ITMI20070140A1
(it)
*
|
2007-01-30 |
2008-07-31 |
Campagnolo Srl |
Dispositivo di interazione uomo-bicicletta
|
|
WO2008124505A2
(en)
*
|
2007-04-05 |
2008-10-16 |
Ironwood Pharmaceuticals,Inc. |
Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
|
|
PT2152712E
(pt)
*
|
2007-05-11 |
2012-02-29 |
Pfizer |
Compostos amino-heterocíclicos
|
|
PT2152663E
(pt)
|
2007-06-04 |
2014-06-03 |
Univ Ben Gurion |
Compostos de triarilo e composições que compreendem os mesmos
|
|
US8648085B2
(en)
|
2007-11-30 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
|
|
KR20100121527A
(ko)
|
2008-02-29 |
2010-11-17 |
콘서트 파마슈티컬즈, 인크. |
치환된 잔틴 유도체
|
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
CN102143965A
(zh)
|
2008-09-08 |
2011-08-03 |
贝林格尔.英格海姆国际有限公司 |
吡唑并嘧啶酮及其在治疗中枢神经系统疾病中的用途
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
TWI404721B
(zh)
|
2009-01-26 |
2013-08-11 |
Pfizer |
胺基－雜環化合物
|
|
US20110053961A1
(en)
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
UY32531A
(es)
|
2009-03-31 |
2010-10-29 |
Boehringer Ingelheim Int |
Nuevos compuestos para el tratamiento de trastornos del snc
|
|
WO2011016861A2
(en)
|
2009-08-05 |
2011-02-10 |
Intra-Cellular Therapies, Inc. |
Novel regulatory proteins and inhibitors
|
|
AR078793A1
(es)
|
2009-10-27 |
2011-12-07 |
Orion Corp |
Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
BR112013003097B1
(pt)
|
2010-08-12 |
2021-03-16 |
Boehringer Ingelheim International Gmbh |
6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
|
|
ES2583528T3
(es)
|
2010-09-07 |
2016-09-21 |
Astellas Pharma Inc. |
Compuesto de pirazoloquinolina
|
|
EP3181566A1
(en)
*
|
2010-09-20 |
2017-06-21 |
Ironwood Pharmaceuticals, Inc. |
Imidazotriazinone compounds
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
US20140296263A1
(en)
|
2011-07-19 |
2014-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
MX381326B
(es)
|
2011-10-10 |
2025-03-12 |
H Lundbeck As |
Derivados de 7h-imidazo[1-5-a]pirazin-8-ona como inhibidores de la fosfodiesterasa 9(pde9); y el uso de los mismos en el tratamiento de trastornos neurodegenerativos
|
|
EP2807163B1
(en)
*
|
2012-01-26 |
2017-03-22 |
H. Lundbeck A/S |
Pde9 inhibitors with imidazo triazinone backbone
|
|
EP2828262A4
(en)
|
2012-03-19 |
2015-09-23 |
Forum Pharmaceuticals Inc |
IMIDAZOTRIAZINONVERBINDUNGEN
|
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
|
US20130323222A1
(en)
|
2012-06-04 |
2013-12-05 |
Matthew Charles |
Human tissue kallikrein 1 glycosylation isoforms
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2014024125A1
(en)
|
2012-08-08 |
2014-02-13 |
Celon Pharma S.A. |
Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors
|
|
CN102786525B
(zh)
|
2012-08-08 |
2014-12-17 |
中山大学 |
N-取代吡唑并[3,4-d]嘧啶酮类化合物、其制备方法及其应用
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
JP2015067538A
(ja)
*
|
2013-09-26 |
2015-04-13 |
株式会社アイエイアイ |
血糖値降下剤
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
EP3065723B1
(en)
|
2013-11-05 |
2020-09-23 |
Ben Gurion University of the Negev Research and Development Authority |
Compounds for the treatment of diabetes and disease complications arising from same
|
|
WO2015160913A1
(en)
|
2014-04-18 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Methods of treating hyperglycemia
|
|
CA2990521C
(en)
|
2015-07-07 |
2023-10-10 |
H. Lundbeck A/S |
Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
|
|
US20180072741A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyrimidine compounds and uses thereof
|
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
AR109596A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos pirazolopiridina y sus usos
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
WO2018152220A1
(en)
|
2017-02-15 |
2018-08-23 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
AU2018230478B2
(en)
|
2017-03-09 |
2025-01-23 |
Diamedica Inc. |
Dosage forms of tissue kallikrein 1
|
|
HUE065158T2
(hu)
|
2017-05-26 |
2024-05-28 |
Cardurion Pharmaceuticals Inc |
PDE9 gátlószereinek elõállítására és alkalmazására szolgáló eljárások
|
|
JP2020523309A
(ja)
|
2017-06-08 |
2020-08-06 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ピラゾロピリミジンｐｄｅ９インヒビター
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
DK3755703T3
(da)
|
2018-02-20 |
2022-06-27 |
Incyte Corp |
N-(phenyl)-2-(phenyl)pyrimidin-4-carboxamidderivater og relaterede forbindelser som hpk1-inhibitorer til behandling af kræft
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
BR112020024019A2
(pt)
|
2018-05-25 |
2021-02-23 |
Imara Inc. |
monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
KR20250108770A
(ko)
|
2018-08-31 |
2025-07-15 |
카듀리온 파마슈티칼스, 인크. |
겸상 세포 질환의 치료를 위한 pde9 억제제
|
|
WO2020068729A1
(en)
|
2018-09-25 |
2020-04-02 |
Incyte Corporation |
Pyrazolo[4,3-d]pyrimidine compounds as alk2 abd/or fgfr modulators
|
|
KR20220059480A
(ko)
|
2019-08-06 |
2022-05-10 |
인사이트 코포레이션 |
고체 형태의 hpk1 억제제
|
|
JP2023550269A
(ja)
*
|
2020-10-27 |
2023-12-01 |
カーデュリオン・ファーマシューティカルズ・インコーポレイテッド |
心不全を治療するためのｐｄｅ９阻害剤
|